WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2017”
Non-ulcer dyspepsia is a term used to describe signs and symptoms of indigestion that have no obvious cause. Non-ulcer dyspepsia is also called functional dyspepsia or non-ulcer stomach pain. Signs and symptoms include burning sensation or discomfort in upper abdomen or lower chest, sometimes relieved by food or antacids, bloating, belching and nausea.
The predisposing factors include consuming excessive amounts of caffeine or alcohol, smoking and taking certain medications, especially certain over-the-counter pain relievers, such as aspirin and ibuprofen (advil, motrin, others), which can cause stomach problems. Treatment includes medications to reduce acid production, antibiotics and low-dose antidepressants.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811465-functional-non-ulcer-dyspepsia-pipeline-review-h1-2018
Major Key Players:
Daewoong Pharmaceutical Co Ltd
RaQualia Pharma Inc
Zeria Pharmaceutical Co Ltd
Pharmaceutical and Healthcare latest pipeline guide Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Functional (Non Ulcer) Dyspepsia , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Functional (Non Ulcer) Dyspepsia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 1, 2 and 1 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.
Functional (Non Ulcer) Dyspepsia pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2811465-functional-non-ulcer-dyspepsia-pipeline-review-h1-2018
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
P: +44 208 133 9349
M: +1 646 845 9349